
Finding the 'key' in leukemia : PIM1 inhibition as a novel therapy in T-cell acute lymphoblastic leukemia
(2020)
- Author
- Renate De Smedt (UGent)
- Promoter
- Pieter Van Vlierberghe (UGent) and Steven Goossens (UGent)
- Organization
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only (changes to open access on 2023-11-24)
- |
- |
- 120.06 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8682988
- MLA
- De Smedt, Renate. Finding the “key” in Leukemia : PIM1 Inhibition as a Novel Therapy in T-Cell Acute Lymphoblastic Leukemia. Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen, 2020.
- APA
- De Smedt, R. (2020). Finding the “key” in leukemia : PIM1 inhibition as a novel therapy in T-cell acute lymphoblastic leukemia. Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen.
- Chicago author-date
- De Smedt, Renate. 2020. “Finding the ‘key’ in Leukemia : PIM1 Inhibition as a Novel Therapy in T-Cell Acute Lymphoblastic Leukemia.” Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen.
- Chicago author-date (all authors)
- De Smedt, Renate. 2020. “Finding the ‘key’ in Leukemia : PIM1 Inhibition as a Novel Therapy in T-Cell Acute Lymphoblastic Leukemia.” Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen.
- Vancouver
- 1.De Smedt R. Finding the “key” in leukemia : PIM1 inhibition as a novel therapy in T-cell acute lymphoblastic leukemia. Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen; 2020.
- IEEE
- [1]R. De Smedt, “Finding the ‘key’ in leukemia : PIM1 inhibition as a novel therapy in T-cell acute lymphoblastic leukemia,” Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen, 2020.
@phdthesis{8682988, author = {{De Smedt, Renate}}, language = {{eng}}, pages = {{XV, 206}}, publisher = {{Universiteit Gent. Faculteit Geneeskunde en Gezondheidswetenschappen}}, school = {{Ghent University}}, title = {{Finding the 'key' in leukemia : PIM1 inhibition as a novel therapy in T-cell acute lymphoblastic leukemia}}, year = {{2020}}, }